StartUp Health tracks funding and other activity related to digital health and has issued a report on the first half of 2016. (StartUp Health Report) Globally 234 companies were funded with $3.9 billion in that time period, compared to 498 at a $2.96 billion rate in the comparable period of 2015. A few large deals skewed the higher funding in 2016. $500 million went to Chinese patient scheduling vendor An Ping Good Doctor. Health insurance received large funding also, with flailing Oscar getting $400 million, Clover Health $160 million and Bright Health $80 million. Big data and analytics also garnered big deals, with Human Longevity at $220 million and Flatiron at $175 million. By category, patient and consumer experience received $958 million; wellness $854 million, personal health and quantified self (my favorite name), $524 million and big data/analytics $406 million. A buzzword blast from the past, population health, has fallen down the list to only $55 million in the first half of 2016. 32% of deals were seed round, 33% Series A, 18% Series B and the rest were C or later. But more of the funding obviously goes to later stage rounds. San Francisco, NYC, San Diego and Boston were the most active geographies. Top investors by numbers of deals include Khosla Ventures, GE Ventures and StartUp Health itself. There were 446 unique investors, indication no lack of interest. About half the deals and half the funding went to 50 companies that are viewed as “hot”. Alas, the ultimate value of many of these companies seems a mystery. For digital health companies going public in 2015, most are down dramatically from the offering price. Fitbit’s stock price has declined 60% and Teladoc’s 51%. Evolent Health is the only gainer at a whopping 1%. I would say that in digital health, the motto should be “buyer beware”.
✅ Subscribe via Email
About this Blog
Healthy Skeptic Podcast
Research
MedPAC 2019 Report to Congress
June 18, 2019
Headlines
Tags
Access
ACO
Care Management
Chronic Disease
Comparative Effectiveness
Consumer Directed Health
Consumers
Devices
Disease Management
Drugs
EHRs
Elder Care
End-of-Life Care
FDA
Financings
Genomics
Government
Health Care Costs
Health Care Quality
Health Care Reform
Health Insurance
Health Insurance Exchange
HIT
HomeCare
Hospital
Hospital Readmissions
Legislation
M&A
Malpractice
Meaningful Use
Medicaid
Medical Care
Medicare
Medicare Advantage
Mobile
Pay For Performance
Pharmaceutical
Physicians
Providers
Regulation
Repealing Reform
Telehealth
Telemedicine
Wellness and Prevention
Workplace
Related Posts
Commentary
Variation in Health Spending
February 16, 2025
Variation in Health Spending
Another interesting analysis of geographic variation in health spending.
Commentary
All Quiet on the Western Front
February 15, 2025
All Quiet on the Western Front
The pre-eminent description of war's impact on those who must fight it was written after…
Commentary
Yesterday’s 30-year US Bond Auction Did Not Go Well
February 14, 2025
Yesterday’s 30-year US Bond Auction Did Not Go Well
Warning signs aplenty if Congress does not get its act together on deficit reduction.